Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics and treatment of the first included patients
Russian Journal of Cardiology,
Journal Year:
2023,
Volume and Issue:
28(10), P. 5593 - 5593
Published: Sept. 5, 2023
Aim.
To
describe
demographic
and
clinical
laboratory
characteristics,
concomitant
diseases
drug
therapy
of
outpatients
with
heart
failure
(HF)
in
the
Russian
Federation.
Material
methods.
An
interim
analysis
a
prospective
observational
multicenter
registry
study
patients
chronic
Federation
("PRIORITET-CHF")
was
performed.
The
included
HF
followed
by
general
practitioner
or
cardiologist.
Results.
Data
from
6255
were
analyzed
(31,3%
sample;
median
age,
65
years;
men,
65%).
reduced
ejection
fraction
(HFrEF)
diagnosed
42,4%,
preserved
EF
—
31,9%.
In
addition,
57,4%
characterized
NYHA
class
II
HF.
most
common
causes
hypertension,
coronary
artery
disease,
atrial
fibrillation
flutter.
Of
diseases,
doctors
often
reported
kidney
disease
(CKD)
(43,2%),
obesity
(37,8%)
diabetes
(26,7%)
Conclusion.
Federation,
among
HF,
there
domination
HFrEF
phenotype,
II.
relatively
young
mean
age
frequent
associations
cardiovascular
risk
factors
underscore
importance
timely
prevention
initiatives.
identified
high
proportion
CKD
requires
special
attention
separate
analysis.
Despite
prescription
rate
certain
classes
diseasemodifying
for
optimal
quadruple
electrophysiological
treatments
is
insufficient.
Language: Английский
Frailty in patients with atrial fibrillation: diagnosis, management, prevention and influence on prognosis
Е. С. Кропачева,
No information about this author
M. I. Dashaeva,
No information about this author
Е. П. Панченко
No information about this author
et al.
Russian Cardiology Bulletin,
Journal Year:
2025,
Volume and Issue:
20(1), P. 5 - 5
Published: April 14, 2025
The
review
is
devoted
to
frailty
in
patients
with
atrial
fibrillation
(AF).
number
of
elderly
AF
constantly
increasing,
and
this
category
characterized
by
high
incidence
stroke
bleeding.
Frailty
a
key
geriatric
syndrome.
Research
extremely
important,
since
involutional
processes
cardiovascular
system,
brain,
kidneys
gastrointestinal
tract
cause
metabolism
anticoagulants
increase
the
risk
thromboembolic
hemorrhagic
complications.
highlights
tools,
scales
questionnaires
for
assessing
diseases.
In
addition,
some
biomarkers
related
syndromes
are
described.
Data
on
negative
impact
prognosis
presented,
measures
prevent
its
progression
outlined.
These
data
indicate
need
introduce
tools
into
interdisciplinary
approach.
This
can
delay
loss
working
capacity,
improve
quality
life
outcomes
senile
AF.
Language: Английский
Factors associated with deterioration of myocardial inotropic function in patients with coronary artery disease
CARDIOVASCULAR THERAPY AND PREVENTION,
Journal Year:
2024,
Volume and Issue:
23(8), P. 4081 - 4081
Published: June 19, 2024
Material
and
methods.
One
hundred
patients
with
functional
class
III-IV
CAD,
stage
I-IIa
heart
failure
LV
ejection
fraction
(EF)
>40%,
successful
coronary
artery
bypass
grafting,
SYNTAX
Score
of
33.
During
hospitalization,
echocardiography,
matrix
metalloproteinase
9
(MMP-9),
tissue
inhibitor
1
(TIMP-1),
monocyte
chemoattractant
protein
(MCP-1)
were
studied,
while
systemic
immune-inflammation
index
(SII)
was
estimated.
After
6
months,
echocardiography
revealed
a
group
decrease
in
LVEF.
Results.
The
following
factors
decreased
LVEF
identified:
type
2
diabetes,
chronic
kidney
disease
(p<0,001),
>4
comorbid
diseases
(r=-0,597,
p<0,001),
increase
SII
by
44,6%
MMP-9
62%
MCP-1
55,1%
TIMP-1
45,8%
(p<0,001).
An
inverse
relationship
found
between
the
level
(r=-0,626,
(r=-0,747,
(r=-0,718,
p<0,001).
There
threshold
values
for
predicting
LVEF:
—
356,43,
318,7
ng/ml,
459,6
pg/ml.
Conclusion.
are
markers
CAD
months
after
surgery:
disease,
diseases,
SII,
value
ng/ml
pg/ml,
respectively.
Language: Английский
Remote Monitoring in Heart Failure Patient: A Review of Non-invasive Approach
Digital Diagnostics,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 5, 2024
Remote
monitoring
(RM)
has
been
actively
developed
in
recent
years,
including
of
patients
with
chronic
heart
failure.
Unlike
invasive
methods,
non-invasive
methods
do
not
involve
surgical
risks
and
offer
a
wide
range
management
options:
telemonitoring,
virtual
visits,
forward
triage,
hospital
telemedicine,
telerehabilitation,
psychological
support.
The
first
RM
was
performed
by
multidisciplinary
team
healthcare
providers
from
different
specialties
showed
effectiveness.
Unfortunately,
attempts
to
use
modern
technology
reduce
human
involvement
have
often
unsuccessful.
However,
the
COVID-19
pandemic
triggered
dramatic
development
mHealth.
Today,
there
is
huge
variety
available,
but
it
still
impossible
give
definitive
answer
about
effectiveness
due
lack
uniform
standards,
imperfect
legislation,
regional,
social
economic
differences
availability
technology.
Nevertheless,
included
European
Society
Cardiology
clinical
guidelines
for
diagnosis
treatment
acute
failure
2021
(IIb).
This
review
focuses
on
history
development,
current
potentially
effective
problems
they
aim
solve,
challenges
society
needs
overcome
them
effectively.
Language: Английский
Sodium-glucose cotransporter type 2 inhibitors in the treatment of chronic heart failure: new evidence
Meditsinskiy sovet = Medical Council,
Journal Year:
2024,
Volume and Issue:
6, P. 187 - 196
Published: May 19, 2024
Rational
pharmacotherapy
for
chronic
heart
failure
(HF)
remains
a
relevant
issue
due
to
the
unfavorable
prognosis.
Several
major
studies
have
confirmed
beneficial
effect
on
reducing
hospitalization
rates
and
mortality
of
modern
disease-modifying
therapy,
including
sodium-glucose
cotransporter
type
2
inhibitors
(SGLT-2
or
gliflozins),
considered
first-line
therapy
regardless
left
ventricular
ejection
fraction
(LVEF)
diabetes
mellitus
in
HF
patients.
The
review
presents
studied
mechanisms
action
this
group
drugs
HF,
metabolic,
hemodynamic,
other
pleiotropic
effects,
through
which
SGLT-2
prevent
development
progression
with
different
LVEF.
possibilities
influence
clinical
symptoms
quality
life
patients
are
discussed,
as
well
change
level
N-terminal
pro-B-type
natriuretic
peptide
target
rational
use
justification.
concept
quadruple
depending
situation,
is
presented,
basis
rapid
simultaneous
initiation
combina-
combination
life-saving
drug
groups
(angiotensin-converting
enzyme
/
sacubitril
+
valsartan,
inhibitors,
beta-blockers,
mineralocorticoid
receptor
antagonists),
aimed
at
improving
condition
Thus,
modern,
effective
approach
managing
LVEF
necessarily
includes
sufficient
evidence
their
category
Language: Английский
Influence of genetic characteristics of patients on systolic and diastolic function after acute myocardial infarction: a literature review
Russian Journal of Cardiology,
Journal Year:
2023,
Volume and Issue:
28(10), P. 5536 - 5536
Published: July 21, 2023
The
most
important
task
in
providing
care
to
patients
with
myocardial
infarction
is
maintaining
contractility.
article
discusses
issues
related
the
influence
of
genetic
characteristics
on
repair
infarcted
myocardium,
remodeling
process,
and
restoration
left
ventricular
systolic
diastolic
function.
One
approach
improving
predictive
ability
testing
combine
information
about
many
nucleotide
sequence
variants
into
a
single
risk
score,
often
called
polygenic
score.
examines
recent
publications
creation
use
scores.
methods
during
examination,
further
consideration
individual
each
patient
when
choosing
therapy
prescribing
course
rehabilitation
will
allow
for
an
patient,
which
turn
should
have
positive
impact
disease
prognosis.
Language: Английский